Akebia Therapeutics Reports First Quarter 2019 Financial Results; Announces Full Enrollment of Phase 3 INNO2VATE Studies and Announces Key Executive Appointments by mparnell | May 9, 2019 | Portfolio News
Sublimity Therapeutics to Present Positive Data for Ulcerative Colitis Drug Candidate by mparnell | May 8, 2019 | Portfolio News
Axonics Announces First Quarter 2019 Financial Results and Operational Update by mparnell | May 8, 2019 | Portfolio News
Aptinyx to Report First Quarter 2019 Financial Results on Tuesday, May 14, 2019 by mparnell | May 6, 2019 | Portfolio News
Kala Pharmaceuticals to Report First Quarter 2019 Financial Results and Host Conference Call by mparnell | May 2, 2019 | Portfolio News